- Home
- RXRX vs PAX Comparison
RXRX vs PAX Comparison
Compare RXRX & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- PAX
- Stock Information
- Founded
- RXRX 2013
- PAX 1988
- Country
- RXRX United States
- PAX Cayman Islands
- Employees
- RXRX N/A
- PAX N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- PAX Investment Managers
- Sector
- RXRX Health Care
- PAX Finance
- Exchange
- RXRX Nasdaq
- PAX Nasdaq
- Market Cap
- RXRX 2.0B
- PAX 1.8B
- IPO Year
- RXRX 2021
- PAX 2021
- Fundamental
- Price
- RXRX $6.18
- PAX $11.92
- Analyst Decision
- RXRX Buy
- PAX Strong Buy
- Analyst Count
- RXRX 6
- PAX 1
- Target Price
- RXRX $9.40
- PAX $14.00
- AVG Volume (30 Days)
- RXRX 5.5M
- PAX 633.3K
- Earning Date
- RXRX 11-06-2024
- PAX 11-05-2024
- Dividend Yield
- RXRX N/A
- PAX 5.03%
- EPS Growth
- RXRX N/A
- PAX N/A
- EPS
- RXRX N/A
- PAX 0.42
- Revenue
- RXRX $65,184,000.00
- PAX $328,717,000.00
- Revenue This Year
- RXRX $50.69
- PAX $1.43
- Revenue Next Year
- RXRX $40.10
- PAX $32.56
- P/E Ratio
- RXRX N/A
- PAX $28.26
- Revenue Growth
- RXRX 37.64
- PAX 7.39
- 52 Week Low
- RXRX $5.89
- PAX $10.63
- 52 Week High
- RXRX $15.74
- PAX $16.16
- Technical
- Relative Strength Index (RSI)
- RXRX 41.15
- PAX 52.65
- Support Level
- RXRX $6.68
- PAX $11.87
- Resistance Level
- RXRX $8.49
- PAX $12.52
- Average True Range (ATR)
- RXRX 0.51
- PAX 0.30
- MACD
- RXRX -0.02
- PAX 0.01
- Stochastic Oscillator
- RXRX 1.07
- PAX 47.37
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About PAX Patria Investments Limited
Patria Investments Ltd is a private markets investment firm. It seeks to provide global and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns.